GAROFALO, Carlo
 Distribuzione geografica
Continente #
EU - Europa 1.218
NA - Nord America 1.135
AS - Asia 387
AF - Africa 19
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.777
Nazione #
US - Stati Uniti d'America 1.123
IE - Irlanda 515
IT - Italia 205
CN - Cina 153
GB - Regno Unito 142
SG - Singapore 116
UA - Ucraina 89
DE - Germania 75
TR - Turchia 64
GR - Grecia 48
RU - Federazione Russa 34
FR - Francia 28
KR - Corea 28
FI - Finlandia 21
CZ - Repubblica Ceca 13
BE - Belgio 12
PH - Filippine 11
SC - Seychelles 11
SE - Svezia 11
BR - Brasile 8
CA - Canada 8
ES - Italia 8
AT - Austria 3
IN - India 3
MK - Macedonia 3
NL - Olanda 3
AR - Argentina 2
CL - Cile 2
CO - Colombia 2
ID - Indonesia 2
IR - Iran 2
MA - Marocco 2
MX - Messico 2
MY - Malesia 2
NI - Nicaragua 2
PL - Polonia 2
RO - Romania 2
RS - Serbia 2
RW - Ruanda 2
TW - Taiwan 2
UG - Uganda 2
AO - Angola 1
CH - Svizzera 1
EG - Egitto 1
EU - Europa 1
HK - Hong Kong 1
JP - Giappone 1
KZ - Kazakistan 1
PE - Perù 1
PT - Portogallo 1
TH - Thailandia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 2.777
Città #
Dublin 515
Chandler 195
Jacksonville 167
Santa Clara 98
Singapore 69
Princeton 67
Roxbury 64
Beijing 58
Medford 57
Istanbul 49
New York 45
Ann Arbor 36
Naples 36
Saint Petersburg 32
Wilmington 27
Caserta 25
Des Moines 23
Nanjing 23
Bremen 21
Seoul 21
Woodbridge 20
Munich 19
Boardman 18
Brno 13
Jinan 13
Brussels 12
Houston 12
Cambridge 10
Zhengzhou 10
San Mateo 9
Milan 8
Redwood City 8
Ashburn 7
Napoli 7
Rome 6
Shenyang 6
Auburn Hills 5
Los Angeles 5
Seattle 5
Shanghai 5
Aversa 4
Frankfurt am Main 4
Helsinki 4
Lappeenranta 4
Mountain View 4
Ottawa 4
Capua 3
Fairfield 3
Hamilton 3
London 3
Nanchang 3
Ningbo 3
Norwalk 3
Prilep 3
Quezon City 3
Taiyuan 3
Taizhou 3
Turin 3
Verona 3
Vienna 3
Bekasi 2
Bitlis 2
Bogotá 2
Brusciano 2
Caloocan City 2
Casablanca 2
Ceglie Messapica 2
Dortmund 2
Gissi 2
Groningen 2
Haikou 2
Halle 2
Imus 2
Kampala 2
Kigali 2
Kraków 2
Kunming 2
Lanzhou 2
Malolos 2
Managua 2
Marano Di Napoli 2
Palermo 2
Pessac 2
Potenza 2
Puebla 2
Rio de Janeiro 2
Santiago 2
Seregno 2
Sorrento 2
Taoyuan District 2
Tianjin 2
Zanjan 2
Acerra 1
Adelfia 1
Afragola 1
Alicante 1
Almaty 1
Amsterdam 1
Andover 1
Bangkok 1
Totale 1.964
Nome #
Reassessment of Ambulatory Blood Pressure Improves Renal Risk Stratification in Nondialysis Chronic Kidney Disease: Long-Term Cohort Study 118
A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population 96
Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care 78
Empagliflozin in Patients with Chronic Kidney Disease 77
[Anti-diabetics and chronic kidney disease] 71
Amino acid loss during dialysis treatment 68
[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease] 66
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease 64
Role of paracalcitol in the management of non-dialysis CKD: state of art and unmeet needs. 59
Atherosclerotic-nephropathy: an updated narrative review 57
Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question 56
[Iron deficiency in ND-CKD: from diagnosis to treatment] 55
Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care 54
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 53
[Epidemiology and prognosis of chronic kidney disease in Italy] 51
[Hyperuricaemia and Chronic Kidney Disease] 50
Blood pressure variability, mortality, and cardiovascular outcomes in CKD patients 48
High-flow arteriovenous fistula and heart failure: could the indexation of blood flow rate and echocardiography have a role in the identification of patients at higher risk? 47
Nephroprotection with saxagliptin 46
Epidemiology of CKD in Italy and prevention strategies 45
Dietary salt restriction in chronic kidney disease: A meta-analysis of randomized clinical trials 45
[Peritoneal dialysis catheter infection with abscess of the abdominal wall in a ADPKD patient] 45
Hypertension and Prehypertension and Prediction of Development of Decreased Estimated GFR in the General Population: A Meta-analysis of Cohort Studies 44
Sodium removal by peritoneal dialysis: a systematic review and meta-analysis 42
Effect of post-nephrectomy acute kidney injury on renal outcome: a retrospective long-term study 41
[Hyperkalemia treatment in chronic kidney disease patients: overview on new cation exchange resins and possible therapeutic approaches] 41
Central Venous Stenosis after Hemodialysis: Case Reports and Relationships to Catheters and Cardiac Implantable Devices 41
Incremental dialysis in ESRD: systematic review and meta-analysis 39
Area Deprivation and Risk of Death and CKD Progression: Long-Term Cohort Study in Patients under Unrestricted Nephrology Care 39
Cost-analysis of persistent hyperkalaemia in non-dialysis chronic kidney disease patients under nephrology care in Italy 38
Prognosis and determinants of serum PTH changes over time in 1-5 CKD stage patients followed in tertiary care 37
Statins in patients with chronic kidney disease: new evidence. 36
Effect of Increased Convection Volume by Mid-Dilution Hemodiafiltration on the Subclinical Chronic Inflammation in Maintenance Hemodialysis Patients 34
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease 34
Limitations of blood pressure target in non-dialysis chronic kidney disease: a question of method ? 32
Ultrasonography in chronic lithium nephropathy: a case report 31
Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer 31
Generalizability of SPRINT-CKD cohort to CKD patients referred to renal clinics 30
Role of Ambulatory Blood Pressure Monitoring (ABPM) in chronic kidney patients: a review 30
[Management of hyperkalemia in Nephrology and Cardiology clinics: reality and perspectives] 30
Sodium toxicity in peritoneal dialysis: mechanisms and "solutions". 30
Current management of hyperkalemia in non-dialysis CKD: Longitudinal study of patients receiving stable nephrology care 30
Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: The role of kidney 29
Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies 28
Ferric carboxymatose in non-hemodialysis ckd patients: A longitudinal cohort study 28
Dipping Status, Ambulatory Blood Pressure Control, Cardiovascular Disease, and Kidney Disease Progression: A Multicenter Cohort Study of CKD 27
Identifying Fabry patients in dialysis population: prevalence of GLA mutations by renal clinic screening, 1995-2019 27
Exercise training in kidney transplant recipients: a systematic review 27
SGLT2 Inhibitors: Nephroprotective Efficacy and Side Effects 26
Sodium intake and chronic kidney disease 26
Prevalence and renal prognosis of left ventricular diastolic dysfunction in non-dialysis chronic kidney disease patients with preserved systolic function 26
Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers 25
Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report 25
Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects 25
Very large abscesses of lower limbs by Nocardia farcinica requiring surgical management in patient with minimal change disease under chronic steroid treatment 25
Remote patient monitoring in dialysis patients: The "change of pace" for home dialysis 24
15-year-change of phenotype and prognosis in non-dialysis CKD patients referred to a nephrology clinic 23
Antiproteinuric effect of paricalcitol in kidney transplant recipients with severe proteinuria: a prospective cohort study 23
Infected hepatic cyst in ADPKD patient in peritoneal dialysis 23
Role of proteinuria in clinical research: For each old-answer, a new key-question 21
Temporal variation of Chronic Kidney Disease's epidemiology 20
Urine chloride self-measurement to monitor sodium chloride intake in patients with chronic kidney disease 19
Precision Nephrology Is a Non-Negligible State of Mind in Clinical Research: Remember the Past to Face the Future 19
Nephroprotection by SGLT2 Inhibition: Back to the Future? 19
Salt intake correlates with night systolic blood pressure in non-dialytic chronic kidney disease 18
Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients 18
Recommendations on nutritional intake of potassium in CKD: it's now time to be more flexible! 17
Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale 17
The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel? 17
Renal resistive index in chronic kidney disease patients: Possible determinants and risk profile 16
Selective endothelin A receptor antagonism in patients with proteinuric chronic kidney disease 15
Sex difference in ambulatory blood pressure control associates with risk of ESKD and death in CKD patients receiving stable nephrology care 15
Generalizability of DAPA-CKD trial to the real-world setting of outpatient CKD clinics in Italy 14
Novel Strategies to Increase Sodium Removal and to Reduce Glucose Exposures in Peritoneal Dialysis 14
Ketoanalogue Supplementation in Patients with Non-Dialysis Diabetic Kidney Disease: A Systematic Review and Meta-Analysis 14
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 13
New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: A multicohort observational study 13
Volume-Independent Sodium Toxicity in Peritoneal Dialysis: New Insights from Bench to Bed 12
The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients 12
Omics in chronic kidney disease: Focus on prognosis and prediction 12
Efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitors in patients with chronic kidney disease: meta-analysis of phase 3 randomized controlled trials 11
Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD 10
Sodium-glucose cotransporter-2 inhibition in a CKD patient with severe heart failure treated by high-dose diuretics and peritoneal ultrafiltration: lesson for the clinical nephrologist 10
Predictive effect of salt intake on patient and kidney survival in non-dialysis CKD: Competing risk analysis in older versus younger patients under nephrology care 9
[Study designs adopted in epidemiology of chronic diseases] 9
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and their Combination in Patients with Chronic Kidney Disease: A Randomized Cross-over Clinical Trial 9
Renal Denervation for Resistant Hypertension: Time to Improve Patient Selection. The Lesson From ADPKD 8
Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms of Trials 8
The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials 8
Efficacy and Safety of Oral Supplementation with Liposomal Iron in Non-Dialysis Chronic Kidney Disease Patients with Iron Deficiency 7
Sex difference in cardiovascular risk in patients with chronic kidney disease: pooled analysis of four cohort studies 7
Editorial: Management of Patients With Non-dialysis Dependent Chronic Kidney Disease (ND-CKD) 7
Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic 7
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial 7
Risk of end-stage kidney disease in kidney transplant recipients versus patients with native chronic kidney disease: multicentre unmatched and propensity-score matched analyses 6
Renal involvement in COVID-19: focus on kidney transplant sector 6
Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: An Italian multicenter prospective study 6
Resistance to erythropoiesis stimulating agents in a dialysis patient after kidney graft failure 6
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial 6
Sustained Recovery of Kidney Function in Patients with ESKD under Chronic Dialysis Treatment: Systematic Review and Meta-Analysis 5
Totale 2.983
Categoria #
all - tutte 17.445
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.445


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020182 0 0 0 0 31 9 47 11 32 11 35 6
2020/2021341 10 9 33 47 81 4 46 22 15 21 51 2
2021/2022397 18 1 2 5 126 9 8 9 19 27 38 135
2022/2023855 68 14 22 63 72 66 3 32 445 12 23 35
2023/2024481 43 12 22 34 157 50 22 7 12 7 42 73
2024/2025309 11 31 16 78 173 0 0 0 0 0 0 0
Totale 2.987